The association of lipoprotein parameters and C-reactive protein in patients with age-related macular degeneration

Ophthalmic Research

Volumn 46, Issue 3, 2011, Pages 125-132

  Čolak, Emina ^a   Kosanović Jaković, Natalija ^b   Žorić, Lepša ^b   Radosavljević, Aleksandra ^b   Stanković, Sanja ^a   Majkić Singh, Nada ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Age related macular degeneration; C reactive protein; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA MACULA AGE RELATED DEGENERATION; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEINS; MACULAR DEGENERATION; MALE;

EID: 79951559006     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000323815     Document Type: Article

References (28)

1. Gu J, Pauer GJT, Yue X, Narendra U, Sturgill GM, Bena J, et al: Proteomic and genomic biomarkers for age-related macular degeneration. Adv Exp Med Biol 2010;664:411-417.
2. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA: Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-424. (Pubitemid 40530082)
3. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH: A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 200 0;70:441-449. (Pubitemid 30662042)
4. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC: Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 1994;112:402-406. (Pubitemid 24085153)
5. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N: Association between C-reactive protein and age-related macular degeneration. JAMA 2004;291:704-710. (Pubitemid 38543790)
6. Vine AK, Stader J, Branham K, Musch DC, Swaroop A: Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005;112:2076-2080. (Pubitemid 41720983)
7. Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, Ridker PM: High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol 2007;125:300-305. (Pubitemid 46425556)
8. Yeh ET, Willerson JT: Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulat ion 20 03;107:370-371.
9. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
10. Age-Related Eye Disease Study Research Group: The Age-Related Eye Disease Study severity scale for age-related macular degeneration. AREDS report No 17. Am J Ophthalmol 2001;132:668-681.
11. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812. (Pubitemid 38057722)
12. Chang MK, Binder CJ, Torzewski M, Witztum JL: C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 20 02;99:13043-1304 8.
13. Scholl HPN, Charbel Issa P, Walier M, et al: Systemic complement activation in age-related macular degeneration. PloS One 2008;3:e2593.
14. De Jong PT, Boekhoorn SS, Vingerling JR, Witteman JCM, Hofman A: C-reactive protein and incident aging macular disease (AMD): the Rotterdam Study. Invest Ophthalmol Vis Sci 2005;46:E-abstract 2379.
15. Kikuchi M, Nakamura M, Ishikawa K, et al: Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007;114:1722-1727. (Pubitemid 47332667)
16. Boekhoorn SS, Vingerling JR, Witteman JCM, Hofman A, De Jong PT: C-reactive protein level and risk of aging macula disorder: the Rotterdam Study. Arch Ophthalmol 2007;125:1396-1401. (Pubitemid 47606607)
17. Boey PY, Tay WTT, Lamoureux E, Tai S, Mitchell P, Wang JJ, Saw SM, Wong TY: C-reactive protein and age-related macular degeneration and cataract: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci 2010;51:1880-1885.
18. Finger RP, Krohne TU, Charbel Issa P, Fleckenstein M, Scholl HPN, Holz FG: Plasmapheresis for dry age-related macular degeneration - evidence based? Retina 2009;29:569-572.
19. Curcio CA, Johnson M, Huang JD, Rudolf M: Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 2010;51:451-467.
20. Curcio CA, Johnson M, Huang JD, Rudolf M: Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res 2009;28:393-422.
21. Despriet DDG, Klaver CCW, Witteman JCM et al: Complement factor H polymorphism, compliment activators and risk of age-related macular degeneration. JAMA 2006;296:301-309. (Pubitemid 44079314)
22. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565. (Pubitemid 35315836)
23. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-reactive protein and the risk of developing hypertension. JAMA 2003;290:2945-2951. (Pubitemid 37505526)
24. Chase HP, Cooper S, Osberg I, et al: Elevated C-reactive protein levels in the development of t ype 1 diabetes. Diabetes 2004;53:2569-2573. (Pubitemid 39299263)
25. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334. (Pubitemid 32656163)
26. Matsumoto K, Sera Y, Ueki Y, Inukai G, Niiro E, Miyake S: Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med 2002;19:822-826. (Pubitemid 35177180)
27. Nagaoka T, Kuo L, Yi Ren Y, Yoshida A, Hein TV: C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 2008;49:2053-2060.
28. Qamirani E, Ren Y, Kuo L, Hein TW: C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD (P) H oxidase. Arterioscler Thromb Vasc Biol 2005;25:995-1001. (Pubitemid 40627845)